Latest Foreign Investment News

Global Uranium and Enrichment Limited has obtained a crucial ASX waiver allowing the cancellation of certain unlisted options without shareholder approval, smoothing the path for Snow Lake Resources’ acquisition scheme.

IMDEX Limited is set to acquire Advanced Logic Technology and Mount Sopris Instruments for nearly A$99 million upfront, significantly boosting its earth science sensor and software capabilities. The deal integrates industry-leading technologies and software, promising to accelerate IMDEX’s subsurface intelligence platform and market reach.

TPC Consolidated’s proposed acquisition by Wollar Holding Ltd hits a regulatory snag as FIRB approval misses the November 28 sunset deadline, casting uncertainty over the deal’s future.

Urenco Limited has secured Foreign Investment Review Board approval for its strategic investment in Ubaryon, where Global Uranium and Enrichment Limited holds a significant stake, marking a key milestone in advancing innovative uranium enrichment technology.

Kingsgate Consolidated and the Thai government have mutually agreed to terminate a long-standing arbitration under TAFTA, signaling renewed cooperation and promising benefits for the Chatree gold and silver mine.

National Storage REIT has received a conditional, non-binding proposal from a Brookfield and GIC consortium to acquire all stapled securities at $2.86 each, triggering an exclusivity period for negotiations.

Invictus Energy updates progress on its AMOG joint venture with Al Mansour Holdings, revealing ongoing negotiations for a significant Qatari ownership stake and deferral of a key placement settlement.

Entertainment Rewards Ltd has issued a Target’s Statement recommending shareholders accept Suzerain Investment Holdings’ conditional off-market takeover offer at a significant premium. An independent expert concurs the offer is fair and reasonable, setting the stage for potential full ownership by Suzerain.

Macquarie Asset Management has tabled a $5.20 per share cash offer to acquire Qube Holdings, valuing the logistics giant at approximately $11.6 billion. The Qube board has entered an exclusivity agreement and signals unanimous support, pending due diligence and regulatory approvals.

The Foreign Investment Review Board has formally objected to Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma, casting serious doubt on the deal’s future and prompting Mayne to explore alternative paths.

Northern Minerals has applied to defer its 2025 AGM as it awaits regulatory review over potential foreign investment breaches, underscoring heightened scrutiny on shareholder compliance.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a brief delay as FIRB extends its approval deadline, prompting a reschedule of the critical court hearing to November 23.